APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pet Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pet Vaccine Industry Growth and Trends Forecast to 2032

20 December 2025113 pages

Choose your research edition.

Industry ResearchPet Vaccine Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Vaccine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pet Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Vaccine Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Vaccine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pet Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Vaccine include CAHIC, Zoetis, Ringpu, Merck Animal Health, Keqian Biology, Jinyu Group, Virbac, Vetoquinol and Parnell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pet Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pet Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pet Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pet Vaccine Market by Company

CAHIC

Zoetis

Ringpu

Merck Animal Health

Keqian Biology

Jinyu Group

Virbac

Vetoquinol

Parnell

Ouro Fino Saude

Meiji

Kyoritsu Seiyaku

Elanco Animal Health

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Animalcare Group

Pet Vaccine Segment by Type

Nasal Administration

Injection

Other

Pet Vaccine Segment by Application

Cat

Dog

Other

Pet Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pet Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nasal Administration Table 2. Major Company of Injection Table 3. Major Company of Other Table 4. Global Pet Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 6. Global Pet Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pet Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pet Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Pet Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Pet Vaccine Sales by Type (2027-2032) & (K Units) Table 11. Global Pet Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pet Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pet Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Pet Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 16. North America Pet Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 18. Europe Pet Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Pet Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Pet Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pet Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Pet Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Pet Vaccine Industry Trends Table 26. Pet Vaccine Industry Drivers Table 27. Pet Vaccine Industry Opportunities and Challenges Table 28. Pet Vaccine Industry Restraints Table 29. Global Pet Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pet Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Pet Vaccine Sales by Company (2021-2026) & (K Units) Table 32. Global Pet Vaccine Sales Share by Company (2021-2026) Table 33. Global Pet Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Pet Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pet Vaccine Major Company Production Sites and Headquarters Table 36. Global Pet Vaccine Company, Product Type & Application Table 37. Global Pet Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pet Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pet Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pet Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Pet Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pet Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pet Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Pet Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Pet Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pet Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pet Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Pet Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Pet Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Pet Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pet Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pet Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Pet Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pet Vaccine Sales by Application (2027-2032) & (K Units) Table 58. Global Pet Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pet Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pet Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Pet Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 63. North America Pet Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 65. Europe Pet Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Pet Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Pet Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pet Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Pet Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. CAHIC Company Information Table 73. CAHIC Business Overview Table 74. CAHIC Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. CAHIC Pet Vaccine Product Portfolio Table 76. CAHIC Recent Development Table 77. Zoetis Company Information Table 78. Zoetis Business Overview Table 79. Zoetis Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Zoetis Pet Vaccine Product Portfolio Table 81. Zoetis Recent Development Table 82. Ringpu Company Information Table 83. Ringpu Business Overview Table 84. Ringpu Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Ringpu Pet Vaccine Product Portfolio Table 86. Ringpu Recent Development Table 87. Merck Animal Health Company Information Table 88. Merck Animal Health Business Overview Table 89. Merck Animal Health Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck Animal Health Pet Vaccine Product Portfolio Table 91. Merck Animal Health Recent Development Table 92. Keqian Biology Company Information Table 93. Keqian Biology Business Overview Table 94. Keqian Biology Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Keqian Biology Pet Vaccine Product Portfolio Table 96. Keqian Biology Recent Development Table 97. Jinyu Group Company Information Table 98. Jinyu Group Business Overview Table 99. Jinyu Group Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Jinyu Group Pet Vaccine Product Portfolio Table 101. Jinyu Group Recent Development Table 102. Virbac Company Information Table 103. Virbac Business Overview Table 104. Virbac Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Virbac Pet Vaccine Product Portfolio Table 106. Virbac Recent Development Table 107. Vetoquinol Company Information Table 108. Vetoquinol Business Overview Table 109. Vetoquinol Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Vetoquinol Pet Vaccine Product Portfolio Table 111. Vetoquinol Recent Development Table 112. Parnell Company Information Table 113. Parnell Business Overview Table 114. Parnell Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Parnell Pet Vaccine Product Portfolio Table 116. Parnell Recent Development Table 117. Ouro Fino Saude Company Information Table 118. Ouro Fino Saude Business Overview Table 119. Ouro Fino Saude Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Ouro Fino Saude Pet Vaccine Product Portfolio Table 121. Ouro Fino Saude Recent Development Table 122. Meiji Company Information Table 123. Meiji Business Overview Table 124. Meiji Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Meiji Pet Vaccine Product Portfolio Table 126. Meiji Recent Development Table 127. Kyoritsu Seiyaku Company Information Table 128. Kyoritsu Seiyaku Business Overview Table 129. Kyoritsu Seiyaku Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Kyoritsu Seiyaku Pet Vaccine Product Portfolio Table 131. Kyoritsu Seiyaku Recent Development Table 132. Elanco Animal Health Company Information Table 133. Elanco Animal Health Business Overview Table 134. Elanco Animal Health Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Elanco Animal Health Pet Vaccine Product Portfolio Table 136. Elanco Animal Health Recent Development Table 137. Dechra Veterinary Products Company Information Table 138. Dechra Veterinary Products Business Overview Table 139. Dechra Veterinary Products Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Dechra Veterinary Products Pet Vaccine Product Portfolio Table 141. Dechra Veterinary Products Recent Development Table 142. Ceva Company Information Table 143. Ceva Business Overview Table 144. Ceva Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Ceva Pet Vaccine Product Portfolio Table 146. Ceva Recent Development Table 147. Boehringer Ingelheim Company Information Table 148. Boehringer Ingelheim Business Overview Table 149. Boehringer Ingelheim Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Boehringer Ingelheim Pet Vaccine Product Portfolio Table 151. Boehringer Ingelheim Recent Development Table 152. Animalcare Group Company Information Table 153. Animalcare Group Business Overview Table 154. Animalcare Group Pet Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Animalcare Group Pet Vaccine Product Portfolio Table 156. Animalcare Group Recent Development Table 157. North America Pet Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. North America Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 159. North America Pet Vaccine Sales Market Share by Country (2021-2026) Table 160. North America Pet Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 161. North America Pet Vaccine Sales Market Share Forecast by Country (2027-2032) Table 162. North America Pet Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. North America Pet Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 164. North America Pet Vaccine Market Share by Country (2021-2026) Table 165. North America Pet Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. North America Pet Vaccine Market Share Forecast by Country (2027-2032) Table 167. Europe Pet Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Europe Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 169. Europe Pet Vaccine Sales Market Share by Country (2021-2026) Table 170. Europe Pet Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 171. Europe Pet Vaccine Sales Market Share Forecast by Country (2027-2032) Table 172. Europe Pet Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Europe Pet Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 174. Europe Pet Vaccine Market Share by Country (2021-2026) Table 175. Europe Pet Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Europe Pet Vaccine Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Pet Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 179. Asia-Pacific Pet Vaccine Sales Market Share by Country (2021-2026) Table 180. Asia-Pacific Pet Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 181. Asia-Pacific Pet Vaccine Sales Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Pet Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Pet Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 184. Asia-Pacific Pet Vaccine Market Share by Country (2021-2026) Table 185. Asia-Pacific Pet Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Asia-Pacific Pet Vaccine Market Share Forecast by Country (2027-2032) Table 187. Latin America Pet Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Latin America Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 189. Latin America Pet Vaccine Sales Market Share by Country (2021-2026) Table 190. Latin America Pet Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 191. Latin America Pet Vaccine Sales Market Share Forecast by Country (2027-2032) Table 192. Latin America Pet Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Latin America Pet Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 194. Latin America Pet Vaccine Market Share by Country (2021-2026) Table 195. Latin America Pet Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Latin America Pet Vaccine Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Pet Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Pet Vaccine Sales by Country (2021-2026) & (K Units) Table 199. Middle East and Africa Pet Vaccine Sales Market Share by Country (2021-2026) Table 200. Middle East and Africa Pet Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 201. Middle East and Africa Pet Vaccine Sales Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Pet Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Pet Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 204. Middle East and Africa Pet Vaccine Market Share by Country (2021-2026) Table 205. Middle East and Africa Pet Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Middle East and Africa Pet Vaccine Market Share Forecast by Country (2027-2032) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Pet Vaccine Distributors List Table 210. Pet Vaccine Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Pet Vaccine Image Figure 2. Global Pet Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Vaccine Sales (2021-2032) & (K Units) Figure 5. Nasal Administration Image Figure 6. Global Nasal Administration Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Pet Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pet Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Pet Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Pet Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Pet Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pet Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pet Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pet Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pet Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pet Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pet Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pet Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pet Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cat Image Figure 26. Global Cat Sales YoY Growth (2021-2032) & (K Units) Figure 27. Dog Image Figure 28. Global Dog Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Pet Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pet Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Pet Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Pet Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Pet Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pet Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pet Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pet Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pet Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pet Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pet Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pet Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Pet Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Pet Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pet Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pet Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Pet Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pet Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pet Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Pet Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pet Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pet Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Pet Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pet Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pet Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Pet Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pet Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pet Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pet Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pet Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Administration
  • Injection
  • Other
Applications
  • Cat
  • Dog
  • Other
Companies covered
  • CAHIC
  • Zoetis
  • Ringpu
  • Merck Animal Health
  • Keqian Biology
  • Jinyu Group
  • Virbac
  • Vetoquinol
  • Parnell
  • Ouro Fino Saude
  • Meiji
  • Kyoritsu Seiyaku
  • Elanco Animal Health
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pet Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pet Vaccine Market by Type
  6. 1.3.1 Nasal Administration
  7. 1.3.2 Injection
  8. 1.3.3 Other
  9. 1.4 Global Pet Vaccine Market Size by Type
  10. 1.4.1 Global Pet Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pet Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pet Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pet Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pet Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pet Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pet Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pet Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pet Vaccine Industry Trends
  2. 2.2 Pet Vaccine Industry Drivers
  3. 2.3 Pet Vaccine Industry Opportunities and Challenges
  4. 2.4 Pet Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pet Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pet Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Pet Vaccine Price (2021-2026)
  4. 3.4 Global Pet Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Pet Vaccine Company, Product Type & Application
  7. 3.7 Global Pet Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Vaccine Tier 1, Tier 2, and Tier 3
4 Pet Vaccine Regional Status and Outlook
  1. 4.1 Global Pet Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pet Vaccine Historic Market Size by Region
  3. 4.2.1 Global Pet Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pet Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pet Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pet Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Pet Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pet Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pet Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pet Vaccine by Application
  1. 5.1 Pet Vaccine Market by Application
  2. 5.1.1 Cat
  3. 5.1.2 Dog
  4. 5.1.3 Other
  5. 5.2 Global Pet Vaccine Market Size by Application
  6. 5.2.1 Global Pet Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pet Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pet Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pet Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pet Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pet Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pet Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pet Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CAHIC
  2. 6.1.1 CAHIC Company Information
  3. 6.1.2 CAHIC Business Overview
  4. 6.1.3 CAHIC Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CAHIC Pet Vaccine Product Portfolio
  6. 6.1.5 CAHIC Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Pet Vaccine Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Ringpu
  14. 6.3.1 Ringpu Company Information
  15. 6.3.2 Ringpu Business Overview
  16. 6.3.3 Ringpu Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ringpu Pet Vaccine Product Portfolio
  18. 6.3.5 Ringpu Recent Developments
  19. 6.4 Merck Animal Health
  20. 6.4.1 Merck Animal Health Company Information
  21. 6.4.2 Merck Animal Health Business Overview
  22. 6.4.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Animal Health Pet Vaccine Product Portfolio
  24. 6.4.5 Merck Animal Health Recent Developments
  25. 6.5 Keqian Biology
  26. 6.5.1 Keqian Biology Company Information
  27. 6.5.2 Keqian Biology Business Overview
  28. 6.5.3 Keqian Biology Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Keqian Biology Pet Vaccine Product Portfolio
  30. 6.5.5 Keqian Biology Recent Developments
  31. 6.6 Jinyu Group
  32. 6.6.1 Jinyu Group Company Information
  33. 6.6.2 Jinyu Group Business Overview
  34. 6.6.3 Jinyu Group Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jinyu Group Pet Vaccine Product Portfolio
  36. 6.6.5 Jinyu Group Recent Developments
  37. 6.7 Virbac
  38. 6.7.1 Virbac Company Information
  39. 6.7.2 Virbac Business Overview
  40. 6.7.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Virbac Pet Vaccine Product Portfolio
  42. 6.7.5 Virbac Recent Developments
  43. 6.8 Vetoquinol
  44. 6.8.1 Vetoquinol Company Information
  45. 6.8.2 Vetoquinol Business Overview
  46. 6.8.3 Vetoquinol Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Vetoquinol Pet Vaccine Product Portfolio
  48. 6.8.5 Vetoquinol Recent Developments
  49. 6.9 Parnell
  50. 6.9.1 Parnell Company Information
  51. 6.9.2 Parnell Business Overview
  52. 6.9.3 Parnell Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Parnell Pet Vaccine Product Portfolio
  54. 6.9.5 Parnell Recent Developments
  55. 6.10 Ouro Fino Saude
  56. 6.10.1 Ouro Fino Saude Company Information
  57. 6.10.2 Ouro Fino Saude Business Overview
  58. 6.10.3 Ouro Fino Saude Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ouro Fino Saude Pet Vaccine Product Portfolio
  60. 6.10.5 Ouro Fino Saude Recent Developments
  61. 6.11 Meiji
  62. 6.11.1 Meiji Company Information
  63. 6.11.2 Meiji Business Overview
  64. 6.11.3 Meiji Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Meiji Pet Vaccine Product Portfolio
  66. 6.11.5 Meiji Recent Developments
  67. 6.12 Kyoritsu Seiyaku
  68. 6.12.1 Kyoritsu Seiyaku Company Information
  69. 6.12.2 Kyoritsu Seiyaku Business Overview
  70. 6.12.3 Kyoritsu Seiyaku Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kyoritsu Seiyaku Pet Vaccine Product Portfolio
  72. 6.12.5 Kyoritsu Seiyaku Recent Developments
  73. 6.13 Elanco Animal Health
  74. 6.13.1 Elanco Animal Health Company Information
  75. 6.13.2 Elanco Animal Health Business Overview
  76. 6.13.3 Elanco Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Elanco Animal Health Pet Vaccine Product Portfolio
  78. 6.13.5 Elanco Animal Health Recent Developments
  79. 6.14 Dechra Veterinary Products
  80. 6.14.1 Dechra Veterinary Products Company Information
  81. 6.14.2 Dechra Veterinary Products Business Overview
  82. 6.14.3 Dechra Veterinary Products Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Dechra Veterinary Products Pet Vaccine Product Portfolio
  84. 6.14.5 Dechra Veterinary Products Recent Developments
  85. 6.15 Ceva
  86. 6.15.1 Ceva Company Information
  87. 6.15.2 Ceva Business Overview
  88. 6.15.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ceva Pet Vaccine Product Portfolio
  90. 6.15.5 Ceva Recent Developments
  91. 6.16 Boehringer Ingelheim
  92. 6.16.1 Boehringer Ingelheim Company Information
  93. 6.16.2 Boehringer Ingelheim Business Overview
  94. 6.16.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Boehringer Ingelheim Pet Vaccine Product Portfolio
  96. 6.16.5 Boehringer Ingelheim Recent Developments
  97. 6.17 Animalcare Group
  98. 6.17.1 Animalcare Group Company Information
  99. 6.17.2 Animalcare Group Business Overview
  100. 6.17.3 Animalcare Group Pet Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Animalcare Group Pet Vaccine Product Portfolio
  102. 6.17.5 Animalcare Group Recent Developments
7 North America by Country
  1. 7.1 North America Pet Vaccine Sales by Country
  2. 7.1.1 North America Pet Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pet Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Pet Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pet Vaccine Market Size by Country
  6. 7.2.1 North America Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pet Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pet Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pet Vaccine Sales by Country
  2. 8.1.1 Europe Pet Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pet Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pet Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pet Vaccine Market Size by Country
  6. 8.2.1 Europe Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pet Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pet Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pet Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Pet Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pet Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pet Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pet Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pet Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pet Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pet Vaccine Sales by Country
  2. 10.1.1 South America Pet Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pet Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Pet Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pet Vaccine Market Size by Country
  6. 10.2.1 South America Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pet Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pet Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pet Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Pet Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pet Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pet Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pet Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Pet Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pet Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pet Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pet Vaccine Value Chain Analysis
  2. 12.1.1 Pet Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pet Vaccine Production Mode & Process
  7. 12.2 Pet Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pet Vaccine Distributors
  10. 12.2.3 Pet Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst